CRISPR gene editing calls into question results of older genetics studies

genomeediting pencil
[Jason Sheltzer, a cancer biologist at Cold Spring Harbor Laboratory in New York] and his team joined an expanding club of laboratories that have been forced to re-evaluate and repeat experiments, as the spread of CRISPR–Cas9 uncovers potential errors in data collected using older techniques.

…

Nathan Lawson, a molecular biologist at the University of Massachusetts Medical School in Worcester, was one of the first to systematically characterize the problem. In 2015, he and his colleagues reported their efforts to compare results from two methods in zebrafish: knocking out genes using a gene-editing technique called zinc finger nucleases, and reducing gene expression using molecular tools called morpholinos. They found that half of the 20 genes they tested yielded different results…

Conflicting results from RNAi and genetic screens do not always mean that one approach was right and the other was wrong, cautions [Michael Bassik, a molecular biologist at Stanford University in California]. Some cells might respond differently to a genetic change that wipes out expression of a gene, as is often the goal with CRISPR–Cas9, compared to how they respond to reducing the expression to very low levels with RNAi.

But often, he adds, the culprit behind the discrepancy can be tracked back to RNAi’s potential for off-target effects. And concerns about that have had researchers flocking to reproduce old results.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: CRISPR studies muddy results of older gene research

For more background on the Genetic Literacy Project, read GLP on Wikipedia

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
ChatGPT-Image-Sep-21-2026-11_54_00-AM
Viewpoint: Activist environmental NGOs are turning from public funding to activist billionaires to support their campaigns. It won’t end well.
Screenshot 2026-08-12 at 1.22
Activists vs. Scientists: Could “Butterfly Effect” fears derail gene-drive research targeting the flesh-eating screwworm?
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
ChatGPT-Image-Sep-22-2026-11_17_31-AM
The exploding controversy over AI’s built-in survival drive
Screenshot-2026-09-16-at-10.27.33-AM
Viewpoint: SCOTUS poised to address First Amendment tension between mandatory vaccines, children’s health and religious freedom 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.